Z

Zenas Biopharma Inc.
D

ZBIO

25.290
USD
-0.48
(-1.86%)
مغلق
حجم التداول
11,037
الربح لكل سهم
-3
العائد الربحي
-
P/E
2
حجم السوق
1,355,398,942
المقالات

العنوان: Zenas Biopharma Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.